Please login to the form below

Not currently logged in
Email:
Password:

Valeant adds member to board of directors

President of ValueAct Capital G. Mason Morfitadded to team
Valeant Mason Morfit

Valeant Pharmaceuticals has added G. Mason Morfit, president of ValueAct Capital to its board of directors, effective immediately.

Morfit also currently serves on the board of directors for Microsoft and was former director of CR Bard, Immucor, Advanced Medical Optics and Solexa prior to his role at ValueAct Capital.

Morfit had originally served on Valeant's board of directors between 2007 and 2014.

Michael Pearson, chairman and CEO of Valeant, said: “I am pleased to welcome Mason back to the Valeant board of directors.

“Although Mason has not officially been a part of the Valeant board for more than a year, I have continued to value his vision and guidance, and I believe his insights will be invaluable during this time.”

26th October 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics